Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

Core Insights - Smith+Nephew has launched a new foot & ankle repair portfolio in Australia and New Zealand featuring proprietary adjustable tensioning technology, which allows surgeons to optimize suture tension after anchor insertion [1][4] - The adjustable tensioning capability enables personalized treatment for patients, potentially improving outcomes by allowing surgeons to tailor the range of motion based on individual activity levels [2][4] - The portfolio includes a best-in-class all suture anchor that ensures consistent deployment and strong fixation, now integrated with needles for open procedures [3] Company Overview - Smith+Nephew is a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue, with a mission to restore people's bodies and self-belief [6] - The company operates in over 100 countries and reported annual sales of $5.5 billion in 2023, being a constituent of the FTSE100 [7]